Laomi Harewood
About Laomi Harewood
Laomi Harewood is the Vice President of GPS Strategy & Business Excellence at Bristol-Myers Squibb, with over 20 years of experience in the pharmaceutical and biotechnology industries.
Title
Laomi Harewood is currently serving as the Vice President, GPS Strategy & Business Excellence at Bristol-Myers Squibb. She assumed this role in November 2019 and leads strategic initiatives within the company's Global Product Strategy (GPS) division.
Education and Expertise
Laomi Harewood pursued her education at the University of Toronto. Her academic background laid the foundation for her extensive career in the pharmaceutical and biotechnology industries, where she has accumulated over 20 years of experience. Her expertise spans clinical operations, medical affairs, strategic planning, and project management.
Professional Background
Laomi Harewood's extensive career began at Apotex Inc. in 1998 as a Clinical Research Associate. She then held a series of positions at Pfizer, Genentech, and Amgen, accumulating significant experience in clinical trials and operations. At Synarc, she functioned as the Director of Project Management for seven months in 2008. Her career continued at Abraxis BioScience as a Senior Program Manager from 2009 to 2011.
Career at Bristol-Myers Squibb
Laomi Harewood has held multiple leadership roles within Bristol-Myers Squibb and its predecessor, Celgene. At Celgene, her roles included Associate Director and Director of Project Management, Senior Director of Medical Affairs Strategic Planning, and Executive Director of Global Medical Affairs Strategic Planning. From 2018 to 2019, she served as VP of Global Corporate Services. In November 2019, she transitioned to her current role as VP, GPS Strategy & Business Excellence at Bristol-Myers Squibb.
Experience in Project Management and Strategic Planning
Throughout her career, Laomi Harewood has been heavily involved in project management and strategic planning. Her roles have emphasized medical affairs, global corporate services, and strategic initiatives within the pharmaceutical sector. Her experience includes senior management positions that required coordination of complex projects and strategic alignment within large organizations.